This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Summanen, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Summanen, P. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2000, p. 733-736, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Comparison of Effects of Medium Composition and Atmospheric Conditions on Detection of Bilophila wadsworthia beta -Lactamase by Cefinase and Cefinase Plus Methods

P. H. Summanen*

Research Service, VA Wadsworth Medical Center, Los Angeles, California

Received 26 July 1999/Returned for modification 26 August 1999/Accepted 6 November 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The influence of growth medium and incubation conditions on the detection of Bilophila wadsworthia beta -lactamase was tested with Cefinase and Cefinase Plus disks. The tests involved aerobic and anaerobic incubation with conventional disk and quantitative tube assays. The production of beta -lactamase was correlated with penicillin G, ampicillin, and ampicillin-sulbactam MICs and inhibition zones on penicillin (2-U) disks. The strains were grown on (i) brucella agar (brucella), (ii) brucella agar supplemented with 1% pyruvate (brucella-pyruvate), and (iii) brucella agar supplemented with 1% taurine (brucella-taurine). With the aerobic disk assay, 100, 100, and 7% of strains were positive after 30 min from growth on brucella-pyruvate, brucella, and brucella-taurine plates, respectively; of strains grown on brucella-taurine, 54% remained negative by the Cefinase assay, and 23% remained negative by the Cefinase Plus assay at 2 h. In quantitative assays, the strains became positive after 30 min from brucella-pyruvate plates and after 1 h from brucella plates. The intensities of the reactions were strongest with brucella-pyruvate plates under anaerobic test conditions. Anaerobic incubation enhanced beta -lactamase detection of growth on brucella-taurine: at 3 h, 85% of strains were positive in comparison to 38% with aerobic incubation. All beta -lactamase-negative strains were susceptible to penicillin G and ampicillin; all beta -lactamase-positive strains were resistant to ampicillin and, with the exception of two strains, penicillin G. In conclusion, beta -lactamase production correlated with susceptibility to penicillin G and ampicillin. Brucella agar supplemented with 1% pyruvate was the most reliable medium for testing B. wadsworthia beta -lactamase, and anaerobic incubation expedited positive results. Brucella agar supplemented with taurine was unsuitable for B. wadsworthia beta -lactamase testing. Cefinase and Cefinase Plus results were in agreement, but Cefinase Plus yielded faster reactions.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bilophila wadsworthia is an anaerobic, gram-negative rod originally isolated from patients with appendicitis and related clinical conditions (1, 2). Since those reports, its isolation from a wide variety of clinical infections, including bacteremia and brain and liver abscesses, has been described (5, 14). beta -Lactamase production occurs with high frequency in B. wadsworthia (12, 13), but the demonstration of B. wadsworthia beta -lactamase has been problematic and inconsistent. Initially, B. wadsworthia was reported as negative for beta -lactamase production (1), and one report failed to demonstrate beta -lactamase production by B. wadsworthia although the antibiogram obtained suggested resistance due to beta -lactamase (11). However, beta -lactamase production was demonstrated in the presence of pyruvate (13), and the enzyme was characterized to be a cephalosporinase (P. Summanen, H. M. Wexler, and S. M. Finegold, unpublished data). Growth conditions as well as aerobic testing conditions have been found to be possible influences on the detection of B. wadsworthia beta -lactamase (13; Summanen et al., unpublished data).

The present study was undertaken to find a method that reliably allows the demonstration of B. wadsworthia beta -lactamase activity in a clinical laboratory setting. Cefinase and Cefinase Plus disks were used for beta -lactamase detection. The influence of growth medium was tested on (i) ready-made commercially available brucella agar; (ii) brucella agar supplemented with 1% pyruvate, which is the recommended medium for B. wadsworthia susceptibility testing (13); and (iii) brucella agar supplemented with 1% taurine (an amino acid found as a constituent of bile), which provides luxuriant growth of B. wadsworthia (H. Laue, U. K. Schumacher, and A. M. Cook, Abstr. Anaerobe Soc. Am. Congr. Anaerobic Bacteria 1998, p. 11). The tests were performed under aerobic and anaerobic conditions. beta -Lactamase production was correlated with susceptibility to penicillin G, ampicillin, and ampicillin-sulbactam.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bacterial strains. Thirty-eight beta -lactamase-positive and three beta -lactamase-negative clinical strains of B. wadsworthia isolated from various clinical specimens, including appendix tissue (including ATCC 49260 [WAL 7959]), peritoneal fluid, intra-abdominal abscess, necrotizing fasciitis, head wound, joint fluid, axillary wound, and knee drainage fluid, were tested. Organisms were maintained at -70°C in double-strength skim milk. For beta -lactamase testing, the strains were subcultured twice on (i) brucella agar (BBL Microbiology Systems, Cockeysville, Md.) supplemented with 5% laked sheep blood, 5 µg of hemin per ml, 1 µg of vitamin K1 per ml, and 1% pyruvic acid (Sigma Chemical Co., St. Louis, Mo.) (brucella-pyruvate); (ii) brucella agar (BBL) supplemented with 5% laked sheep blood, 5 µg of hemin per ml, 1 µg of vitamin K1 per ml, and 1% taurine (Sigma) (brucella-taurine); and (iii) ready-made commercially available brucella agar plates supplemented with 5% sheep blood, 5 µg of hemin per ml, and 1 µg of vitamin K1 per ml (BBL) (brucella). All tests were performed with subcultures from the respective brucella blood agar.

Chemicals. Cefinase, Cefinase Plus, and penicillin (2-U) disks were obtained from BBL Microbiology Systems, and triphenyltetrazolium chloride was obtained from Sigma Chemical Co. Ampicillin (Pfizer Inc., New York, N.Y.), penicillin G (Eli Lilly and Company, Indianapolis, Ind.), and sulbactam (Pfizer) were obtained from the manufacturers and prepared by the methods outlined in the National Committee for Clinical Laboratory Standards (NCCLS) reference method (8).

Cefinase and Cefinase Plus quantitative assays. Fourteen strains were grown for 48 h on brucella, brucella-pyruvate, and brucella-taurine media. A heavy suspension (McFarland standard of 5 to 6) of organisms on each medium was prepared in distilled water. Two hundred microliters of this suspension was distributed in four tubes, Cefinase and Cefinase Plus disks were added, and the tubes were vortexed. One set of the tubes was incubated inside an anaerobic chamber, and one set was incubated aerobically at +35°C. The color change was inspected visually for 3 h (Table 1) and scored from 0 to 5 on the basis of intensity.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   beta -Lactamase testing of B. wadsworthia strains comparing three different media, Cefinase and Cefinase Plus disks, and aerobic and anaerobic testing conditions

Cefinase and Cefinase Plus disk assays. beta -Lactamase production was measured for strains grown for 48 h on the three brucella agar media by the chromogenic cephalosporin disk method (Cefinase and Cefinase Plus; BBL), as described by the manufacturer. A loopful of bacterial mass from brucella-pyruvate and -taurine plates was inoculated on the disks placed in empty petri dishes, followed by a drop of distilled water. B. wadsworthia grows very poorly on brucella agar without pyruvate or taurine. Therefore, several plates were inoculated, a heavy suspension (with a McFarland standard of >7) of the growth was harvested in distilled water, and 50 µl of this suspension was inoculated onto the disks. The test disks were incubated at room temperature aerobically and anaerobically, with the petri dish lids closed to prevent drying. The reaction was monitored for up to 2 h and visually scored.

Penicillin (2-U) disk assays. The strains were grown for 48 h on brucella and brucella-pyruvate. From the growth on each medium, a suspension equal to McFarland standard 0.5 was prepared in 3-ml dilution blank tubes (Anaerobe Systems, San Jose, Calif.). By using the Kirby-Bauer technique, brucella and brucella-pyruvate plates were inoculated, and penicillin disks were placed on the plates. The plates were incubated anaerobically for 72 h. The zones around the disks were measured, and a zone diameter of >20 mm was considered to indicate sensitivity (6).

Susceptibility studies. The antimicrobial susceptibility studies were performed by using the NCCLS-approved Wadsworth agar dilution technique outlined in NCCLS document M11-A4 (8) and the spiral gradient technique (User guide, Spiral System Instruments, Bethesda, Md.). Bacteroides fragilis ATCC 25285 and Bacteroides thetaiotaomicron ATCC 29741 were included for quality control. All of the MIC determinations were performed on brucella agar supplemented with 1% pyruvic acid to enhance the growth of B. wadsworthia. The MICs were interpreted with the aid of triphenyltetrazolium chloride as described previously (13). The precise penicillin G MICs for strains WAL 7966 and WAL 9009 were also tested with the Etest method (3).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cefinase and Cefinase Plus quantitative assays. The results for Cefinase and Cefinase Plus tube tests are listed in Table 1. The beta -lactamase-negative strain included as an internal quality control (WAL 7813) remained negative in all the tests. The color development (intensity) on tests from brucella-pyruvate plates was faster than that from brucella or brucella-taurine plates. Anaerobic incubation generally yielded faster and stronger reactions. The reactions were always equal to or somewhat stronger with the Cefinase Plus method than with the Cefinase method.

Cefinase and Cefinase Plus disk assays. Table 1 lists the results for conventional Cefinase disk assays. There was no significant difference between the anaerobic and aerobic incubations with the disk assays; therefore, only the aerobic results are shown here. The average intensities of tests from brucella-pyruvate plates were stronger than those from brucella or brucella-taurine plates. All beta -lactamase-producing strains from brucella-pyruvate and brucella plates, but only one from brucella-taurine plates, turned positive after 30 min of incubation.

Penicillin (2-U) disk assays. The zones around penicillin 2 unit disks obtained on brucella and brucella-pyruvate plates are listed in Table 2. Overall, the zone diameters were a few millimeters larger on brucella-pyruvate plates. Three beta -lactamase-negative strains (WAL 7813, WAL 8658, and WAL 9344) showed zone diameters of 27 mm on brucella-pyruvate plates and of 27, 25, and 16 mm on brucella plates, respectively. All but one of the beta -lactamase-producing strains produced zones of <= 20 mm, and beta -lactamase-negative strains produced zones of >20 mm. The one exception was the beta -lactamase-positive strain WAL 7966; it showed a 22-mm-diameter zone around the penicillin (2-U) disk on brucella-pyruvate (18 mm on brucella), and the penicillin MIC for this strain was 0.5 µg/ml. The zones on brucella plates were difficult to interpret due to a very slight, transparent growth pattern. On brucella-pyruvate plates, the growth was heavier and the zones were easy to read.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Correlation of B. wadsworthia beta -lactamase, penicillin (2-U) disk zone diameters, and penicillin G and ampicillin MICs

Susceptibility studies. The results of the antimicrobial susceptibility studies are listed in Table 2. Thirty-six strains were resistant to penicillin, and thirty-eight were resistant to ampicillin (MIC > 0.5). The addition of sulbactam lowered the ampicillin MICs two- to sixfold. The MICs of penicillin for five strains, including two beta -lactamase-positive strains (WAL 7966 and WAL 9009), indicated susceptibility (MIC <=  0.5). Penicillin G MICs for both WAL 7966 and WAL 9009 were 0.38 µg/ml each as determined by the Etest.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Our previous study showed that 87% of B. wadsworthia strains were beta -lactamase positive (13). Similarly, a recent report found 90.8% of 87 B. wadsworthia strains to be beta -lactamase positive (12). The present study suggests that the incidence could be even higher: of 21 strains deposited in the culture collection as beta -lactamase negative, only three remained negative after repeated testing when prolonged incubation and a heavy inoculum from brucella-pyruvate medium were used. These strains were within the first 120 B. wadsworthia strains deposited in the Wadsworth Anaerobe Laboratory collection, thus suggesting that the incidence of beta -lactamase production may actually exceed 97%.

B. wadsworthia beta -lactamase is a cephalosporinase and is nonreactive with the acidometric penicillinase test (Summanen et al., unpublished data). The chromogenic cephalosporin nitrocefin has been found to be effective in detecting all known beta -lactamases (10). The Cefinase and Cefinase Plus methods use chromogenic cephalosporin nitrocefin and a nonnitrocefin chromogenic cephalosporin, respectively. B. wadsworthia beta -lactamase was detected with 100% agreement by the Cefinase and Cefinase Plus methods; the Cefinase Plus method generally produced a color intensity equal to or stronger than that of the Cefinase method. Similar results have been reported in previous evaluations of various other anaerobic and aerobic organisms (4, 7).

B. wadsworthia grows luxuriantly on taurine-containing media (Laue et al., Abstr. Anaerobe Soc. Am. Congr. Anaerobic Bacteria 1998, p. 11), and an adequate inoculum for beta -lactamase tests was easy to obtain from brucella-taurine plates. However, the detection of beta -lactamase was clearly affected by taurine, since 62% of the strains remained negative in the aerobic tube tests. Anaerobic testing conditions markedly enhanced the detection of beta -lactamase production from strains on this medium, but three strains still remained negative at 3 h. The demonstration of beta -lactamase production with the conventional disk test from brucella-taurine plates was slow and insensitive, and the reactions were difficult to interpret since the colonies on this medium were dark grey, which interfered with interpretation of the test.

The growth pattern of B. wadsworthia is very fastidious on commonly used nonselective media, such as brucella and CDC agars. For demonstration of beta -lactamase production from brucella medium, several plates were required to obtain adequate inoculum. The growth of B. wadsworthia is enhanced on brucella-pyruvate plates, and brucella-pyruvate is the recommended medium for susceptibility testing (13). The beta -lactamase tests done with this medium produced stronger and faster reactions than those done with brucella or brucella-taurine. The tube test was clear and easy to interpret, and the color intensities were significantly higher at 15 min to 1 h than those with the other test media. Anaerobic incubation led to faster reactions, but after 1 h of incubation, the color intensity in some of the test tubes started fading; this did not occur in tubes incubated aerobically until after 3 h of incubation. The conventional disk test produced positive reactions within 15 min. As with the brucella-taurine medium, but to a lesser degree, the greyish colony color sometimes interfered with reading the disk tests when brucella-pyruvate plates were used.

The penicillin and ampicillin MICs obtained correlated with beta -lactamase production and the NCCLS guidelines (8), with the exception of those for two strains for which beta -lactamase production was demonstrated but for which the penicillin MICs were in the susceptible range (0.5 µg/ml). However, ampicillin MICs were 4 µg/ml for these strains, indicating resistance. According to the NCCLS guidelines, beta -lactamase-positive organisms should be considered resistant to penicillin regardless of the MIC (8). Sulbactam significantly lowered the ampicillin MICs, further demonstrating that B. wadsworthia beta -lactam resistance is due to beta -lactamase.

Penicillin (2-U) disk susceptibilities correlated with beta -lactamase production and MICs: a strain producing a zone of <= 20 mm should be suspected to be beta -lactamase positive and confirmed by beta -lactamase testing. The penicillin (2-U) disk is generally used for susceptibility testing of aerobic bacteria, but it has also been reported to be useful in screening for beta -lactamase production in anaerobic gram-negative bacilli (6, 9).

In conclusion, the results of this study indicate that a vast majority (97%) of B. wadsworthia strains produce beta -lactamase and that routine beta -lactamase testing in the clinical laboratory may not even be necessary. The beta -lactamase production by B. wadsworthia was most reliably demonstrated with pyruvate-containing medium. Brucella supplemented with taurine was unsuitable for B. wadsworthia beta -lactamase detection. The tube test was easier to interpret than the conventional disk test. The reaction occurred faster anaerobically; however, aerobic incubation yielded comparable results. B. wadsworthia beta -lactamase tests should be interpreted after 30 min of incubation. In detecting beta -lactamase, Cefinase and Cefinase Plus tests were in agreement; Cefinase Plus yielded somewhat faster reactions.


    ACKNOWLEDGMENTS

I thank M. Jane Flynn for technical assistance.

This work was supported by Veterans Administration Medical Research Funds.


    FOOTNOTES

* Mailing address: Anaerobic Bacteriology Research Laboratory, Bldg. 500, Room 1289A, VA Wadsworth Medical Center, Los Angeles, CA 90073. Phone: (310) 478-3711, ext. 41061. Fax: (310) 268-4721. E-mail: PHSummanen{at}aol.com.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Baron, E. J., P. Summanen, J. Downes, M. C. Roberts, H. M. Wexler, and S. M. Finegold. 1989. Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. J. Gen. Microbiol. 135:3405-3411[Abstract/Free Full Text].
2. Bennion, R. E., E. J. Baron, J. E. Thompson, J. Downes, P. Summanen, D. A. Talan, and S. M. Finegold. 1990. The bacteriology of gangrenous and perforated appendicitis---revisited. Ann. Surg. 211:165-171[Medline].
3. Citron, D. M., M. I. Ostovari, A. Karlsson, and E. J. C. Goldstein. 1991. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J. Clin. Microbiol. 29:2197-2203[Abstract/Free Full Text].
4. Doern, G. V., R. N. Jones, E. H. Gerlach, J. A. Washington, D. J. Biedenbach, A. Brueggemann, M. E. Erwin, C. Knapp, and J. Raymond. 1995. Multicenter clinical laboratory evaluation of a beta -lactamase disc assay employing a novel chromogenic cephalosporin, SI. J. Clin. Microbiol. 33:1665-1667[Abstract].
5. Finegold, S. M., and H. Jousimies-Somer. 1997. Recently described clinically important anaerobic bacteria: medical aspects. Clin. Infect. Dis. 25(Suppl.2):S88-S93.
6. Könönen, E., S. Nyfors, J. Mättö, S. Asikainen, and H. Jousimies-Somer. 1997. B-lactamase production by oral pigmented Prevotella species isolated from young children. Clin. Infect. Dis. 25(Suppl.2):S272-S274.
7. Marshall, S. A., L. D. Sutton, and R. N. Jones. 1995. Evaluation of SI chromogenic cephalosporin beta -lactamase disc assay tested against gram-positive anaerobes, coagulase-negative staphylococci, Prevotella spp., and Enterococcus spp. Diagn. Microbiol. Infect. Dis. 22:353-355[CrossRef][Medline].
8. National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 4th ed., vol. 17. , no. 22. Approved standard M11-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
9. Nyfors, S., E. Könönen, A. Takala, and H. Jousimies-Somer. 1999. beta -Lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy. Antimicrob. Agents Chemother. 43:1591-1594[Abstract/Free Full Text].
10. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method for detection of beta -lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288[Abstract/Free Full Text].
11. Schumacher, U. K. 1997. Comparison of the Etest and a microbroth dilution system (Sceptor) to a reference agar dilution method for susceptibility testing of Bilophila wadsworthia. Eur. J. Clin. Microbiol. Infect. Dis. 3:246-249.
12. Schumacher, U. K., and B. Single. 1998. Susceptibility of the anaerobic gram-negative non-sporulating rod, Bilophila wadsworthia, to beta-lactams, beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and quinolones. Zentbl. Bakteriol. 287:421-425.
13. Summanen, P., H. M. Wexler, and S. M. Finegold. 1992. Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination. Antimicrob. Agents Chemother. 36:1658-1664[Abstract/Free Full Text].
14. Summanen, P. H., H. Jousimies-Somer, S. Manley, et al. 1995. Bilophila wadsworthia isolates from clinical specimens. Clin. Infect. Dis. 20(Suppl.2):s210-s211.


Journal of Clinical Microbiology, February 2000, p. 733-736, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Summanen, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Summanen, P. H.